1,3,3,5,5-五甲基環己胺
化合物
1,3,3,5,5-五甲基環己胺（英語：1,3,3,5,5-pentamethylcyclohexanamine，或稱為Neramexane）是一種美金剛胺相關藥物，分子式為C11H23N[1]，作為一種NMDA受體拮抗劑[2]，具有神經保護作用[3]。
 | |
| 臨床資料 | |
|---|---|
| ATC碼 |
|
| 識別資訊 | |
| |
| CAS號 | 219810-59-0  |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.107.752 |
| 化學資訊 | |
| 化學式 | C11H23N |
| 摩爾質量 | 169.31 g·mol−1 |
| 3D模型（JSmol） | |
| |
| |
參考文獻
- ^ Gilling K, Jatzke C, Wollenburg C, Vanejevs M, Kauss V, Jirgensons A, Parsons CG. A novel class of amino-alkylcyclohexanes as uncompetitive, fast, voltage-dependent, N-methyl-D-aspartate (NMDA) receptor antagonists--in vitro characterization. Journal of Neural Transmission. 2007, 114 (12): 1529–37. PMID 17728997. S2CID 8654883. doi:10.1007/s00702-007-0792-7.
- ^ Danysz W, Parsons CG, Jirgensons A, Kauss V, Tillner J. Amino-alkyl-cyclohexanes as a novel class of uncompetitive NMDA receptor antagonists. Current Pharmaceutical Design. 2002, 8 (10): 835–43. PMID 11945134. doi:10.2174/1381612024607117.
- ^ Danysz W, Parsons CG. Neuroprotective potential of ionotropic glutamate receptor antagonists. Neurotoxicity Research. March 2002, 4 (2): 119–26. PMID 12829411. S2CID 9413469. doi:10.1080/10298420290015872.